Cargando…
Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides
A series of novel isatine-sulphonamide derivatives have been synthesized by combining isatin derivatives with sulphonamides. The structure of the synthesized compounds were elucidated by spectral analysis (IR, NMR and Mass). Investigation of anti-HIV activity was done against HIV-1(IIIB) in MT-4 cel...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040873/ https://www.ncbi.nlm.nih.gov/pubmed/21369440 http://dx.doi.org/10.4103/0250-474X.49121 |
_version_ | 1782198388927758336 |
---|---|
author | Selvam, P. Murugesh, N. Chandramohan, M. Debyser, Z. Witvrouw, M. |
author_facet | Selvam, P. Murugesh, N. Chandramohan, M. Debyser, Z. Witvrouw, M. |
author_sort | Selvam, P. |
collection | PubMed |
description | A series of novel isatine-sulphonamide derivatives have been synthesized by combining isatin derivatives with sulphonamides. The structure of the synthesized compounds were elucidated by spectral analysis (IR, NMR and Mass). Investigation of anti-HIV activity was done against HIV-1(IIIB) in MT-4 cells and HIV integrase inhibitory activity. 4-(1-acetyl-5-methyl-2-oxoindolin-3-ylideneamino)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (SPIII-5ME-AC) inhibits the HIV Integrase enzymatic activity as both over all and strand transfer reaction and 4-(1-benzoyl-5-chloro-2-oxoindolin-3-ylideneamino)-N-(4,6-dimethylpyrimidin-2-yl)benzene sulfonamide (SPIII-5Cl-BZ) exhibits 36 percent maximum protection against HIV-1 at sub toxic concentration. |
format | Text |
id | pubmed-3040873 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-30408732011-03-02 Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides Selvam, P. Murugesh, N. Chandramohan, M. Debyser, Z. Witvrouw, M. Indian J Pharm Sci Short Communication A series of novel isatine-sulphonamide derivatives have been synthesized by combining isatin derivatives with sulphonamides. The structure of the synthesized compounds were elucidated by spectral analysis (IR, NMR and Mass). Investigation of anti-HIV activity was done against HIV-1(IIIB) in MT-4 cells and HIV integrase inhibitory activity. 4-(1-acetyl-5-methyl-2-oxoindolin-3-ylideneamino)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (SPIII-5ME-AC) inhibits the HIV Integrase enzymatic activity as both over all and strand transfer reaction and 4-(1-benzoyl-5-chloro-2-oxoindolin-3-ylideneamino)-N-(4,6-dimethylpyrimidin-2-yl)benzene sulfonamide (SPIII-5Cl-BZ) exhibits 36 percent maximum protection against HIV-1 at sub toxic concentration. Medknow Publications 2008 /pmc/articles/PMC3040873/ /pubmed/21369440 http://dx.doi.org/10.4103/0250-474X.49121 Text en © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Communication Selvam, P. Murugesh, N. Chandramohan, M. Debyser, Z. Witvrouw, M. Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides |
title | Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides |
title_full | Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides |
title_fullStr | Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides |
title_full_unstemmed | Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides |
title_short | Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides |
title_sort | design, synthesis and antihiv activity of novel isatine-sulphonamides |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040873/ https://www.ncbi.nlm.nih.gov/pubmed/21369440 http://dx.doi.org/10.4103/0250-474X.49121 |
work_keys_str_mv | AT selvamp designsynthesisandantihivactivityofnovelisatinesulphonamides AT murugeshn designsynthesisandantihivactivityofnovelisatinesulphonamides AT chandramohanm designsynthesisandantihivactivityofnovelisatinesulphonamides AT debyserz designsynthesisandantihivactivityofnovelisatinesulphonamides AT witvrouwm designsynthesisandantihivactivityofnovelisatinesulphonamides |